abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
3121SR: CA 125 with serial reporting Print View
CA 125 IA  < 35  U/mL 

PRIMARY
1 Serum 2 (0.4) mL   Room Temperature - 10 Day(s)/Refrigerated - 12 Day(s)/Frozen - 28 Day(s)  
ALTERNATE

Monitor the course of ovarian cancer, patient response to treatment, and disease recurrence. Serum CA 125 concentrations are elevated in about 80% of women with carcinoma of the ovary, 26% of women with benign ovarian tumors and 66% of women with non-neoplastic conditions, but in only 3% of normal healthy women. A 125 should not be used alone to diagnose or screen for cancer, but it is useful for monitoring patients with an established diagnosis of a gynecological malignancy that is associated with elevated CA 125 at diagnosis.

Transport Temperature: Room temperature
Setup Schedule
Sunday-Saturday

Reported (Analytical Time)
Next day

CPT Code
86304

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Diagnostic code required for third party reimbursement.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database